Skip to main content
SpringerLink
Log in

Antimicrobial activity of topical agents against Propionibacterium acnes: an in vitro study of clinical isolates from a hospital in Shanghai, China

  • Research Article
  • Published:
Frontiers of Medicine Aims and scope Submit manuscript

Abstract

This study aimed to compare the antimicrobial activities of topical agents against Propionibacterium acnes isolated from patients admitted to a hospital in Shanghai, China. The minimal inhibitory concentrations of the cultured P. acnes were determined in accordance with the Clinical and Laboratory Standards Institute. Susceptibilities to clindamycin and erythromycin were compared in terms of gender, age, disease duration, previous treatment, and disease severity. A total of 69 P. acnes strains were isolated from 98 patients (70.41%). The susceptibility to triple antibiotic ointment (neomycin/bacitracin/polymyxin B) and bacitracin was 100%. The susceptibility to fusidic acid was 92.7%. The resistance rates to neomycin sulfate, erythromycin, and clindamycin were 11.7%, 49.3%, and 33.4%, respectively. The high resistance rate to clindamycin and erythromycin was significantly affected by gender, previous treatment, and disease severity rather than by age and disease duration. Topical antibiotics should not be used separately for long-term therapy to avoid multiresistance. The use of topical antibiotics should be determined by clinicians on the basis of clinical conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Beylot C, Auffret N, Poli F, Claudel JP, Leccia MT, Del Giudice P, Dreno B. Propionibacterium acnes: an update on its role in the pathogenesis of acne. J Eur Acad Dermatol Venereol 2014; 28(3): 271–278

    Article  PubMed  CAS  Google Scholar 

  2. Haider A, Shaw JC. Treatment of acne vulgaris. JAMA 2004; 292(6): 726–735

    Article  PubMed  CAS  Google Scholar 

  3. Ross JI, Snelling AM, Carnegie E, Coates P, Cunliffe WJ, Bettoli V, Tosti G, Katsambas A, Galvan Peréz Del Pulgar JI, Rollman O, Török L, Eady EA, Cove JH. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003; 148(3): 467–478

    Article  PubMed  CAS  Google Scholar 

  4. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, Shalita AR, Thiboutot D; Global Alliance to Improve Outcomes in Acne. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49(1 Suppl): S1–S37

    Article  PubMed  Google Scholar 

  5. Bonomo RA, Van Zile PS, Li Q, Shermock KM, McCormick WG, Kohut B. Topical triple-antibiotic ointment as a novel therapeutic choice in wound management and infection prevention: a practical perspective. Expert Rev Anti Infect Ther 2007; 5(5): 773–782

    Article  PubMed  CAS  Google Scholar 

  6. Cesur S. Topical antibiotics and clinical use. Mikrobiyol Bul 2002; 36(3-4): 353–361

    PubMed  Google Scholar 

  7. Khorvash F, Abdi F, Kashani H H, Fatemi Naeini F, Khorvash F. Efficacy of mupirocin and rifampin used with standard treatment in the management of acne vulgaris. Iran J Pharm Res 2013; 12(1): 223–227

    PubMed  PubMed Central  CAS  Google Scholar 

  8. Ramli R, Malik AS, Hani AF, Jamil A. Acne analysis, grading and computational assessment methods: an overview. Skin Res Technol 2012; 18(1): 1–14

    Article  PubMed  Google Scholar 

  9. Dreno B, Gollnick HP, Kang S, Thiboutot D, Bettoli V, Torres V, Leyden J. Understanding innate immunity and inflammation in acne: implications for management. J Eur Acad Dermatol Venereol 2015; 29(Suppl 4): 3–11

    Article  PubMed  Google Scholar 

  10. Rathi SK. Acne vulgaris treatment: the current scenario. Indian J Dermatol 2011; 56(1): 7–13

    Article  PubMed  PubMed Central  Google Scholar 

  11. Del Rosso JQ, Kim GK. Topical antibiotics: therapeutic value or ecologic mischief? Dermatol Ther (Heidelb) 2009; 22(5): 398–406

    Article  Google Scholar 

  12. Tan HH. Antibacterial therapy for acne: a guide to selection and use of systemic agents. Am J Clin Dermatol 2003; 4(5): 307–314

    Article  PubMed  Google Scholar 

  13. Aubin GG, Portillo ME, Trampuz A, Corvec S. Propionibacterium acnes, an emerging pathogen: from acne to implant-infections, from phylotype to resistance. Med Mal Infect 2014; 44(6): 241–250

    Article  PubMed  CAS  Google Scholar 

  14. Del Rosso J. Emerging topical antimicrobial options for mild-tomoderate acne: a review of the clinical evidence. J Drugs Dermatol 2008; 7(2 Suppl): s2–s7

    PubMed  Google Scholar 

  15. Tanghetti E. The impact and importance of resistance. Cutis 2007; 80(1 Suppl): 5–9

    PubMed  Google Scholar 

  16. Yun HJ, Lee SW, Yoon GM, Kim SY, Choi S, Lee YS, Choi EC, Kim S. Prevalence and mechanisms of low- and high-level mupirocin resistance in staphylococci isolated from a Korean hospital. J Antimicrob Chemother 2003; 51(3): 619–623

    Article  PubMed  CAS  Google Scholar 

  17. Bonamonte D, Belloni Fortina A, Neri L, Patrizi A. Fusidic acid in skin infections and infected atopic eczema. G Ital Dermatol Venereol 2014; 149(4): 453–459

    PubMed  CAS  Google Scholar 

  18. Williamson DA, Monecke S, Heffernan H, Ritchie SR, Roberts SA, Upton A, Thomas MG, Fraser JD. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale. Clin Infect Dis 2014; 59(10): 1451–1454

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, 200040, China

    Ying Ma & Nanxue Zhang

  2. Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, 200040, China

    Shi Wu & Haihui Huang

  3. Nursing Department, Huashan Hospital, Fudan University, Shanghai, 200040, China

    Yanpei Cao

Authors
  1. Ying Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nanxue Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shi Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Haihui Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yanpei Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yanpei Cao.

Additional information

These authors contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ma, Y., Zhang, N., Wu, S. et al. Antimicrobial activity of topical agents against Propionibacterium acnes: an in vitro study of clinical isolates from a hospital in Shanghai, China. Front. Med. 10, 517–521 (2016). https://doi.org/10.1007/s11684-016-0480-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-016-0480-9

Keywords

Search

Navigation